This message was sent to ##Email##
To advertise in this publication please click here
Advertisement
|
|
Advertisement
|
The race is on. As we watch the New Matter: Inside the Lives of SLAS Scientists grow, we’ve noticed a spike in downloads with regards to two particular episodes, “Delivering Tailored Therapies to Cancer Patients” with Gregory Vladimer, Ph.D. (Allcyte) and “From COVID to CANVASS” with Matt Hall, Ph.D. (NIH/NCATS). Hall will also be presenting at SLAS Transformed 2020: Virtual Science + Collaboration event. We’re always interested in a little friendly competition here at SLAS, so we’d love to see which episode wins out by the end of this week. Hosted on Buzzsprout, you can find it on a variety of podcast players including iHeartRadio, Apple Podcasts, Spotify, Stitcher, Google Podcasts and more.
|
More Speakers Confirmed, Schedule-at-a-Glance Added for SLAS Transformed (Everywhere, June 23-24)
SLAS
Join researchers and technology providers from around the world on June 23 - 24 for an online event blending virtual science and collaboration to bring you interactive and dynamic sessions on ‘omics, synthetic biology, genome editing and a look at technology and tactics used to battle the pandemic. To date, featured speakers and sessions include:
- Detection of SARS-CoV-2 with the CRISPR-based DETECTR Platform
Janice Chen, Ph.D. (Mammoth Biosciences)
- Synthetic Biology -- Biology by Design
Jim Collins, Ph.D. (Massachusetts Institute of Technology)
- Matthew Hall, Ph.D. (NIH/ National Center for Advancing Translational Science)
- Applying AI to Accelerate Assay Development to Pandemic Speed
Imran Haque, Ph.D. (Recursion Pharmaceuticals)
- Testing Multiple Approaches to Decrease Sequencing Costs and Efficiently Distribute Sequencing Reads for Simultaneous Protein and mRNA Quantification at the Single Cell Level
Stefanie Mortimer, Ph.D. (BD Biosciences)
- Identifying Regional Outbreak and Spread of COVID-19 from Population-wide Surveys
Eran Segal, Ph.D. (Weizmann Institute of Science)
- Ultrasensitive Protein Assays for the COVID-19 Pandemic
David Walt, Ph.D. (Harvard University)
- Hansjörg Wyss, Ph.D. (Harvard Medical School)
Check the event page for NEW programming, exhibit and sponsorship updates. Registration will open soon.
VIEW UP-TO-DATE DETAILS
|
|
Advertisement
|
|
 |
|
The coronavirus (COVID-19) is a rapidly evolving threat, and the synthetic DNA that can help discover a vaccine and treatment is needed now — not in eight to ten weeks. SGI-DNA is supporting front-line researchers in combating the spread of COVID-19 by offering $50,000 in co-funding for the BioXp™ 3200 system.
|
|
One More Week to Tidy up Your Research for Two November Symposia
SLAS
Next Monday, May 25, is the final day to submit a podium abstract for one (or both!) of two November symposia. Registration for both events will open in July.
SLAS 2020 AI Meets Sample Management Symposium
November 4 - 5
Boston, MA, USA
Podium abstracts are being accepted in the areas of:
- blockchain,
- target validation,
- the overlap of digital pathology and clinical data automation, and
- off-the-shelf AI.
ABSTRACT SUBMISSION DETAILS
SLAS 2020 Building Biology in 3D Symposium
November 17 - 18
Scripps Research, Jupiter, FL, USA
Podium abstracts are being accepted on the following topics:
- enabling technologies,
- high-throughput advanced cellular models,
- advances in imaging and analysis and
- complex translational models.
VIEW CALL FOR ABSTRACT SUBMISSION DETAILS
VIEW SCHEDULE AT A GLANCE
|
|
Iscaffpharma
 Sortina Pharma use Iscaffpharma’s patient derived scaffolds to create drug fingerprints and select drugs for aggressive cancer. Read Case
Exhibitors and Sponsors: Get Access to Your Customers this November
SLAS
A wide variety of sponsor and exhibit opportunities are available at the SLAS 2020 AI Meets Sample Management and SLAS 2020 Building Biology in 3D Symposia. Both events offer companies the chance to engage one-on-one with two distinct target audiences filled with data and research scientists, academics, engineers and technology providers. Opportunities are available for both events. Contact Amanda Schermerhorn for more information.
|
|
Calendar of Important Dates
SLAS
SLAS Journal Calls for Papers
High-Throughput Screening, Disease Modeling & Translational Medicine
SLAS Technology
Submission deadline: June 15
Approaches for Prioritizing High-Quality Chemical Matter in Probe and Drug Discovery
SLAS Discovery
Submission deadline: July 1
Applications of Biophysics in Early Drug Discovery
SLAS Discovery
Submission deadline: July 15
SLAS Events Outlook
SLAS is committed to providing a safe meeting space, high-quality education and meaningful networking opportunities for all attendees, whether in person or on a virtual platform, as circumstances warrant. We look forward to convening in person but will do so only if we can provide a safe and appropriate meeting venue as well as suitable accommodations for travelers. The SLAS team is monitoring all aspects of event logistics and solidifying plans to enable alternative forms of knowledge sharing.
COMPLETE LIST OF SLAS CONFERENCES AND SYMPOSIA
Save the Date
SLAS 2020 AI Meets Sample Management Symposium – Call for Abstracts Deadline Is Monday, May 25
Boston, MA, USA
November 4 – 5, 2020
SLAS 2020 Building Biology in 3D Symposium – Call for Abstracts Deadline Is Monday, May 25
Scripps Research, Jupiter, FL, USA
November 17 – 18, 2020
SLAS 2021 International Conference and Exhibition — Call for Abstracts Now Open!
San Diego, CA, USA
January 23 – 27, 2021
|
|
 |
|
Promoted by
Thermo Scientific
The Thermo Scientific™ Orbitor™ RS2 microplate mover is a collaborative bench-top mover that provides unbeatable reliability and improved process efficiency. It’s innovative bi-directional telescoping arm coupled with it’s expansive 360° workspace provide exceptional reach and precision, making the Orbitor RS2 your trusted laboratory productivity partner.
|
|
SARS-CoV-2 Spike Foiled by Antibody Duo
Genetic Engineering & Biotechnology News
Two human neutralizing antibodies have been isolated that bind to the glycoprotein spike of the SARS-CoV-2 virus and thereby prevent the virus from entering host cells. Although the antibodies appear capable of working alone — each binds a different epitope on the spike’s receptor binding domain — they may work better as a team, that is, if they are administered together in an antibody “cocktail.”
|
|
SARS-CoV-2-Fighting T Cells Found in Recovered Patients
The Scientist
Even as researchers around the world rush to develop a vaccine against the virus that causes COVID-19, and some pin their hopes on the idea that enough people will recover from infections to achieve herd immunity in the meantime, questions about whether exposure to the virus induces immunity to it have lingered. If the virus itself does not prompt immunity, a vaccine against it might not either.
|
|
 |
|
Evotec’s broad range of sample management capabilities in drug discovery and
 bioanalysis, many years of experience and continued investments in innovation and technology enable us to meet all customers’ needs and deadlines. Find out how the expertise of a global leader in sample management can help your projects.
|
|
COVID-19 Could Take a Toll on CO2-Reduction Efforts
Chemical & Engineering News
For the first time in living memory, fish are swimming in clear waters in Venetian canals, London’s air is fresh, and New York City’s traffic noise has eased to a gentle hum. Such are the unintended consequences of measures designed to control COVID-19, the disease caused by the novel coronavirus.
Another silver lining is that worldwide carbon emissions are on track to fall 14% this year. With chemical production also falling across the industrial world, it would appear that chemical firms and others seeking to slash greenhouse gas emissions will be able to meet their targets more readily.
|
|
Concerning Elusive Crystal Forms: The Case of Paracetamol
Journal of the American Chemical Society
Increasing commercial application of state of the art crystal structure prediction to aid solid form discovery of new molecular entities allows the experimentalist to target the polymorphs with desired properties. Here we remind ourselves that in this field the gap between such prediction and experimentation can be vast, the latter depending strongly on kinetic processes not accounted for in the computations. Nowhere is this gap more evident than in examples of so-called “elusive” polymorphs, forms that have been found difficult to crystallize, sometimes taking years to appear or sometimes disappearing altogether.
|
|
Machine Learning Cracks Quantum Chemistry Conundrum
Science Daily
A new machine learning tool can calculate the energy required to make — or break — a molecule with higher accuracy than conventional methods. While the tool can currently only handle simple molecules, it paves the way for future insights in quantum chemistry.
"Using machine learning to solve the fundamental equations governing quantum chemistry has been an open problem for several years, and there's a lot of excitement around it right now," says co-creator Giuseppe Carleo.
|
|
Long-Acting Injectable Drug Prevents HIV Infections
Science Magazine
It’s not an AIDS vaccine but it may be the closest thing to one so far. A long-acting antiretroviral drug given as an injection every two months powerfully protected uninfected people from HIV in a large-scale study that was disrupted by the COVID-19 pandemic. The apparent success — the study has not been published in a peer-reviewed journal or presented to HIV researchers at a meeting — offers a potentially easier alternative to taking daily pills of other antiretrovirals, which has proved difficult for many people.
|
|
'Lean Lab' Approach Enables Quick Research Ramp Down
Lab Manager
When MIT announced in March that most research labs on campus would need to ramp down to help prevent the spread of COVID-19, Canan Dagdeviren's lab was ready.
For the past two years, Dagdeviren and her lab manager, David Sadat, have run the Conformable Decoders Group using "lean lab" management principles, working closely with MIT's Environment, Health and Safety Office (EHS). Every item in their lab has an assigned function and location, and there are strict procedures in place describing how everything is to be used, put away, and replenished.
|
|
Formate Dehydrogenase Reduces Carbon Dioxide to Formic Acid
Phys.org
Professor Yutaka Amao of the Osaka City University Artificial Photosynthesis Research Center and Ryohei Sato, a 1st year Ph.D. student of the Graduate School of Science majoring in Physics and Chemistry, reveal that the catalyst formate dehydrogenase reduces carbon dioxide directly to formic acid.
The development of an effective catalyst is an important step in creating an artificial photosynthesis system that uses sunlight to convert carbon dioxide into organic molecules.
|
|
Job Seekers: Post your résumé and sign up for new job alerts by keyword.
Employers: Search résumés, post an open position, internship or post-doc opportunity. SLAS Premier and Corporate Members get a discount on all new job postings.
Postdoctoral Research Position in Immunology at UCLA
University of California, Los Angeles
US – CA – Los Angeles
Research Scientist
Stony Brook University
US – NY – Stony Brook
Assistant/Associate Professor of Biochemistry
Indiana University
US – IN – Bloomington
Search Jobs at SLAS Career Connections
| . |
| THANK YOU |
|
2020 SLAS CORPORATE MEMBERS |
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
